| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Editas Medicine, Inc. (EDIT) has 3 insiders with recent SEC Form 4 filings, including 2 buys and 20 sells. EDIT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 269.1K | $723.8K | - | |
| VP | 68.8K | $185.0K | - | |
| CFO | 15.9K | $42.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 1, 2018 | Bosley Katrine | President And CEO | Sell | 8,333 | $37.55 | $312,872.91 | -0.2% | |
| May 23, 2018 | Albright Charles | Chief Scientific Officer | Sale+OE | 10,000 | $35.00 | $350,000.00 | -100% | |
| May 18, 2018 | Mullen James C | Director | Buy | 10,000 | $38.03 | $380,252.00 | New | |
| May 17, 2018 | Hopfield Jessica | Director | Buy | 6,700 | $37.28 | $249,780.02 | New | |
| May 1, 2018 | Bosley Katrine | President And CEO | Sell | 8,333 | $31.95 | $266,239.35 | -0.6% | |
| Apr 2, 2018 | Bosley Katrine | President And CEO | Sell | 8,333 | $32.16 | $267,969.39 | -0.3% | |
| Mar 20, 2018 | Hack Andrew A. F.62 | Chief Financial Officer | Sale+OE | 40,000 | $38.06 | $1,522,440.00 | -100% | |
| Mar 9, 2018 | Bosley Katrine | President And CEO | Sell | 9,134 | $45.00 | $411,030.00 | -0.7% | |
| Mar 1, 2018 | Bosley Katrine | President And CEO | Sell | 8,333 | $35.72 | $297,693.13 | -0.2% | |
| Feb 16, 2018 | Hack Andrew A. F.62 | Chief Financial Officer | Sale+OE | 18,000 | $34.21 | $615,840.00 | -100% |